These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 23763364)

  • 1. Istaroxime stimulates SERCA2a and accelerates calcium cycling in heart failure by relieving phospholamban inhibition.
    Ferrandi M; Barassi P; Tadini-Buoninsegni F; Bartolommei G; Molinari I; Tripodi MG; Reina C; Moncelli MR; Bianchi G; Ferrari P
    Br J Pharmacol; 2013 Aug; 169(8):1849-61. PubMed ID: 23763364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SERCA2a stimulation by istaroxime: a novel mechanism of action with translational implications.
    Huang CL
    Br J Pharmacol; 2013 Oct; 170(3):486-8. PubMed ID: 23822610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Istaroxime, a stimulator of sarcoplasmic reticulum calcium adenosine triphosphatase isoform 2a activity, as a novel therapeutic approach to heart failure.
    Micheletti R; Palazzo F; Barassi P; Giacalone G; Ferrandi M; Schiavone A; Moro B; Parodi O; Ferrari P; Bianchi G
    Am J Cardiol; 2007 Jan; 99(2A):24A-32A. PubMed ID: 17239701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing phospholamban to sarco(endo)plasmic reticulum Ca2+-ATPase 2a (SERCA2a) protein binding interactions in human cardiac sarcoplasmic reticulum vesicles using chemical cross-linking.
    Akin BL; Jones LR
    J Biol Chem; 2012 Mar; 287(10):7582-93. PubMed ID: 22247554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SERCA2a stimulation by istaroxime improves intracellular Ca2+ handling and diastolic dysfunction in a model of diabetic cardiomyopathy.
    Torre E; Arici M; Lodrini AM; Ferrandi M; Barassi P; Hsu SC; Chang GJ; Boz E; Sala E; Vagni S; Altomare C; Mostacciuolo G; Bussadori C; Ferrari P; Bianchi G; Rocchetti M
    Cardiovasc Res; 2022 Mar; 118(4):1020-1032. PubMed ID: 33792692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular Mechanisms Underlying the Low Cardiotoxicity of Istaroxime.
    Racioppi MF; Burgos JI; Morell M; Gonano LA; Vila Petroff M
    J Am Heart Assoc; 2021 Jul; 10(14):e018833. PubMed ID: 34219467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of sarcoplasmic reticulum function by PST2744 [istaroxime; (E,Z)-3-((2-aminoethoxy)imino) androstane-6,17-dione hydrochloride)] in a pressure-overload heart failure model.
    Rocchetti M; Alemanni M; Mostacciuolo G; Barassi P; Altomare C; Chisci R; Micheletti R; Ferrari P; Zaza A
    J Pharmacol Exp Ther; 2008 Sep; 326(3):957-65. PubMed ID: 18539651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HNO enhances SERCA2a activity and cardiomyocyte function by promoting redox-dependent phospholamban oligomerization.
    Sivakumaran V; Stanley BA; Tocchetti CG; Ballin JD; Caceres V; Zhou L; Keceli G; Rainer PP; Lee DI; Huke S; Ziolo MT; Kranias EG; Toscano JP; Wilson GM; O'Rourke B; Kass DA; Mahaney JE; Paolocci N
    Antioxid Redox Signal; 2013 Oct; 19(11):1185-97. PubMed ID: 23919584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac Function.
    Arici M; Ferrandi M; Barassi P; Hsu SC; Torre E; Luraghi A; Ronchi C; Chang GJ; Peri F; Ferrari P; Bianchi G; Rocchetti M; Zaza A
    J Pharmacol Exp Ther; 2023 Jan; 384(1):231-244. PubMed ID: 36153005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining SERCA2a activation and Na-K ATPase inhibition: a promising new approach to managing acute heart failure syndromes with low cardiac output.
    Gheorghiade M; Ambrosy AP; Ferrandi M; Ferrari P
    Discov Med; 2011 Aug; 12(63):141-51. PubMed ID: 21878191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting SERCA2a as an innovative approach to the therapy of congestive heart failure.
    Ferrari P; Micheletti R; Valentini G; Bianchi G
    Med Hypotheses; 2007; 68(5):1120-5. PubMed ID: 17113239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermolecular conformational coupling and free energy exchange enhance the catalytic efficiency of cardiac muscle SERCA2a following the relief of phospholamban inhibition.
    Mahaney JE; Albers RW; Waggoner JR; Kutchai HC; Froehlich JP
    Biochemistry; 2005 May; 44(21):7713-24. PubMed ID: 15909986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superinhibitory phospholamban mutants compete with Ca2+ for binding to SERCA2a by stabilizing a unique nucleotide-dependent conformational state.
    Akin BL; Chen Z; Jones LR
    J Biol Chem; 2010 Sep; 285(37):28540-52. PubMed ID: 20622261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transmembrane peptide DWORF activates SERCA2a via dual mechanisms.
    Li A; Yuen SL; Stroik DR; Kleinboehl E; Cornea RL; Thomas DD
    J Biol Chem; 2021; 296():100412. PubMed ID: 33581112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of reversal of phospholamban inhibition of the cardiac Ca2+-ATPase by protein kinase A and by anti-phospholamban monoclonal antibody 2D12.
    Chen Z; Akin BL; Jones LR
    J Biol Chem; 2007 Jul; 282(29):20968-76. PubMed ID: 17548345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structural basis for phospholamban inhibition of the calcium pump in sarcoplasmic reticulum.
    Akin BL; Hurley TD; Chen Z; Jones LR
    J Biol Chem; 2013 Oct; 288(42):30181-30191. PubMed ID: 23996003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective SERCA2a activator as a candidate for chronic heart failure therapy.
    Arici M; Hsu SC; Ferrandi M; Barassi P; Ronchi C; Torre E; Luraghi A; Chang GJ; Ferrari P; Bianchi G; Peri F; Zaza A; Rocchetti M
    J Transl Med; 2024 Jan; 22(1):77. PubMed ID: 38243248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New N-aryl-N-alkyl-thiophene-2-carboxamide compound enhances intracellular Ca
    Nikolaienko R; Bovo E; Yuen SL; Treinen LM; Berg K; Aldrich CC; Thomas DD; Cornea RL; Zima AV
    Biophys J; 2023 Jan; 122(2):386-396. PubMed ID: 36463408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Co-expression of the canine cardiac Ca2+ pump and phospholamban in Spodoptera frugiperda (Sf21) cells reveals new insights on ATPase regulation.
    Autry JM; Jones LR
    J Biol Chem; 1997 Jun; 272(25):15872-80. PubMed ID: 9188486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcoplasmic reticulum Ca2+-ATPase modulates cardiac contraction and relaxation.
    Frank KF; Bölck B; Erdmann E; Schwinger RH
    Cardiovasc Res; 2003 Jan; 57(1):20-7. PubMed ID: 12504810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.